Respiratory

FDA-cleared Flowflex Plus 4-in-1 home test detects RSV, influenza A/B, and COVID-19 in adults and children as young as 6 months.

Influenza antiviral use among hospitalized US children declined during the late COVID-19 pandemic despite guideline recommendations.

Pertussis often presents as a prolonged cold, especially in infants. Early recognition, treatment, and vaccination are key to reducing severe disease and spread.

Children hospitalized for bronchiolitis who received high-flow nasal cannula therapy were more likely to be diagnosed with asthma in early childhood.

Experts say recent CDC vaccine schedule changes may complicate clinician–family communication without altering the underlying evidence supporting pediatric vaccination.

Shilpa Patel, MD, MPH, says pediatricians can effectively lead asthma care by emphasizing education, trust, and frequent reassessment.

Check out the top 5 nutrition articles of 2025.

Climate lag time poses urgent health risks for children, necessitating proactive pediatric care and policy changes to address future climate-related challenges.

The SWIFT-1 and -2 phase 3 trials demonstrated "significantly" lower rate of annualized asthma exacerbations in patients receiving twice-yearly depemokimab vs placebo.

According to multiple reports, the FDA is investigating the safety of a pair of already-approved protective treatments for respiratory syncytial virus.

Updated 2025 CPR guidelines from the AAP and AHA include revisions to pediatric and neonatal resuscitation, reflecting new evidence and a unified chain of survival.

Combined or individual use of maternal RSVpreF and infant nirsevimab achieved high antibody levels without safety concerns, supporting current RSV prevention strategies.

A recently immigrated mother from India presents in preterm labor at 32 6/7 weeks and delivers a vigorous baby whose initial blood culture is positive at 18 hours of life with gram-negative rods.

Low-dose methylprednisolone is as effective as high-dose for severe pediatric MPP and has fewer side effects, supporting safer treatment strategies.

Brensocatib was granted FDA priority review in February 2025 for the small molecule, oral, reversible inhibitor.

Richard J. Wong, DO; and Tyra Bryant-Stephens, MD, outline strategies for controlling asthma as kids head back to school.

Pediatric experts emphasize the importance of asthma action plans, medication readiness, and school-based support to help children with asthma stay healthy and active during the academic year.

Tyra Bryant-Stephens, MD, encourages families to revisit asthma triggers, refill medications, and manage allergies to prevent avoidable complications.

Can you guess the diagnosis?

Nirsevimab reduced RSV-related illness by up to 98% and lowered the amount of hospitalizations and health care use among healthy term infants in a real-world study.

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis.

Pediatric pulmonologist Richard Wong, DO, outlines how school environments can complicate asthma management for children across all age groups.

According to research from 2021 to 2023, approximately 50% of adolescents who vaped had tried to quit in the last 12 months.

Mycoplasma pneumoniae caused 1 in 2 pediatric pneumonia hospitalizations in 2024, with sharp increases seen across all age groups, according to a recent CDC MMWR report.